Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wellgistics Health (WGRX) EPS (Weighted Average and Diluted) (2024 - 2025)

Wellgistics Health's EPS (Weighted Average and Diluted) history spans 2 years, with the latest figure at -$0.25 for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 150.0% year-over-year to -$0.25, compared with a TTM value of -$0.92 through Dec 2025, down 534.05%, and an annual FY2025 reading of -$1.43, down 853.33% over the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.25 at Wellgistics Health, up from -$0.46 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was -$0.0 in Q1 2024, with the low at -$0.62 in Q1 2025.